Clinical Trials Browser

Completed × Roflumilast × Clear all

NCT03458546 2024-02-21

Study of Roflumilast in Combination With Standard Chemotherapy for High-risk Diffuse Large B-cell Lymphoma

Phase 1 Completed

Lymphoma, B-Cell

NCT01888952 2017-02-27

Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)

Phase EARLY_PHASE1 Completed

10 enrolled 4 charts

Advanced B-cell Lymphoid Malignancies